Plasma endothelin-1 levels in Behcet's disease.

Authors: Uslu, T  Erem, C  Tosun, M  Deger, O 
Citation: Uslu T, etal., Clin Rheumatol. 1997 Jan;16(1):59-61.
Pubmed: (View Article at PubMed) PMID:9132327

Plasma concentrations of endothelin-1 (ET-1), a vasoconstrictor peptide released from vascular endothelial and synovial cells, were measured by radioimmunoassay in 27 patients with Behcet's disease (BD) and 18 healthy controls. The plasma ET-1 concentrations were found to be significantly increased in patients with BD (121.15 +/- 11.6 fmol/dl) compared with the healthy subjects (89.37 +/- 8.03 fmol/dl p < 0.05). The elevation of ET-1 did not correlate with the disease duration, gender, ocular or articular involvement. Whether the elevated ET-1 level is a direct result of its increased synthesis from injured vascular endothelial cells or whether its presence in high concentrations may be responsible, together with other factors for both vascular and articular complications in patients with BD is uncertain.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 8661801
Created: 2014-06-17
Species: All species
Last Modified: 2014-06-17
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.